CNBC’s Jim Cramer advises trimming AI-driven tech gains and shifting capital to undervalued financial and healthcare stocks.
Jim Cramer warned investors on July 21, 2026, to reduce exposure to high-flying tech stocks, citing Micron’s 758% annual gain as a signal to lock in profits. He recommended rotating proceeds into financials like JPMorgan, trading at 15 times earnings, and healthcare names such as Eli Lilly, which he views as more attractive than Novo Nordisk amid recent weakness.
The call follows a broader market trend where AI-related stocks have surged, while sectors like banking and healthcare have lagged. Cramer emphasized disciplined position sizing, urging investors to trim half of red-hot holdings to avoid volatility. Recent earnings from major banks have reinforced his preference for sectors with cleaner valuations and steady earnings growth.
Futures pointed higher on semiconductor strength, but Cramer’s strategy leans against the crowd, favoring sectors that have underperformed the AI rally. His approach prioritizes risk management over outright sector bets, though he stopped short of predicting a tech downturn.